GlassScriptPhysician profile
Darin Kimball Allred
NPI 1538377585
$34,171.36
in general payments reported to CMS, 2019-2025
26 companies · $22K in 2025
The $22K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,087 · 2020: $2,934 · 2021: $1,825 · 2022: $580 · 2023: $635 · 2024: $1,078 · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $6,593 · Food and Beverage: $4,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,049.72 |
| Travel and Lodging | $6,592.83 |
| Food and Beverage | $4,103.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Development Corporation | $14,118.50 | 2022-2025 | |
| Depuy Synthes Sales INC. | $6,414.58 | 2019-2025 | Velys, Attune |
| Medical Device Business Services, INC. | $5,467.46 | 2019-2025 | Attune, Velys |
| Stryker Corporation | $3,712.06 | 2019-2022 | |
| Orthalign INC | $1,062.74 | 2021-2025 | Orthalign Plus |
| Zimmer Biomet Holdings, INC. | $729.77 | 2019-2023 | |
| Microport Orthopedics INC | $716.36 | 2021 | |
| Omnilife Science, INC | $411.43 | 2019-2025 | |
| Boston Scientific Corporation | $358.30 | 2024-2025 | Artisan, Wavewriter Alpha Prime 16, Infinion 16 |
| Nevro Corp. | $154.68 | 2019-2020 | |
| Goode Surgical INC | $147.72 | 2019 | |
| Bone Support INC. | $144.45 | 2024 | Cerament G, Ceramentbone Void Filler |
| Uoc USA INC | $96.00 | 2021 | |
| Smith+Nephew, INC. | $84.29 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $82.42 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $80.09 | 2022 | |
| Sanara Medtech INC. | $68.88 | 2025 | Celleraterx |
| Innovation Technologies INC | $67.48 | 2020 | |
| Medtronic, INC. | $57.26 | 2024-2025 | Aquamantys(Tm), Intellis Adaptivestim |
| Tenex Health INC. | $52.21 | 2021 | |
| Ethicon US, LLC | $40.93 | 2025 | Stratafix, Vistaseal |
| Maxx Orthopedics, INC. | $31.85 | 2019 | |
| Amgen INC. | $21.92 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.71 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $17.52 | 2025 | |
| Merck Sharp & Dohme LLC | $13.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darin Allred listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.